Beta-Amyloid and Tau-Protein: Structure, Interaction, and Prion-Like Properties

Area of Science:

• Neuroscience
• Molecular Biology
• Genetics

Background:

• Molecular genetic studies over 20 years have advanced Alzheimer's disease (AD) understanding.
• A clear concept of AD molecular pathogenesis is still lacking, hindering therapeutic development.

Purpose of the Study:

• To review the generation of beta-amyloid peptide and Tau-protein in AD.
• To analyze the interaction and combined effects of these proteins in AD pathogenesis.
• To explore therapeutic strategies targeting protein interactions and propagation.

Main Methods:

• Literature review of molecular genetic investigations.
• Analysis of protein generation and interaction mechanisms.
• Examination of toxic effects on cellular pathways and receptors.

Main Results:

• Beta-amyloid peptide and Tau-protein are central to AD genesis.
• These proteins, previously studied independently, must be analyzed together.
• Their interaction influences cellular signaling and neurotransmitter receptors.

Conclusions:

• Understanding the interplay between beta-amyloid and Tau is crucial for AD therapy.
• Targeting both intracellular interactions and extracellular spread of toxic proteins is a promising therapeutic avenue.
• New pharmaceutical substances can be developed based on these combined mechanisms.